{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:37:26Z","timestamp":1792849046359,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guizhou Provincial Science and Technology Projects","award":["Basic Research) MS [2025] 372"],"award-info":[{"award-number":["Basic Research) MS [2025] 372"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00204-026-04488-8","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:28:14Z","timestamp":1782736094000},"page":"5195-5210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["From data mining to mechanistic prediction: a study on drug-induced lung injury integrating FAERS, machine learning, and network toxicology"],"prefix":"10.1007","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9870-246X","authenticated-orcid":false,"given":"Yihuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaofeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"4488_CR1","first-page":"1609","volume":"24","author":"M Abbas","year":"2025","unstructured":"Abbas M, Sami SHA, Gajd\u00e1cs M, Tariq MJ (2025) Recent FDA-approved kinase inhibitors for cancer therapy in 2025: a comprehensive review and perspectives. EXCLI J 24:1609","journal-title":"EXCLI J"},{"issue":"D1","key":"4488_CR2","doi-asserted-by":"publisher","first-page":"D789","DOI":"10.1093\/nar\/gku1205","volume":"43","author":"JS Amberger","year":"2015","unstructured":"Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A (2015) OMIM. org: Online Mendelian Inheritance in Man (OMIM\u00ae), an online catalog of human genes and genetic disorders. Nucleic Acids Res 43(D1):D789\u2013D798","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"4488_CR3","doi-asserted-by":"publisher","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","volume":"49","author":"SK Burley","year":"2021","unstructured":"Burley SK, Bhikadiya C, Bi C et al (2021) RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res 49(D1):D437\u2013D451","journal-title":"Nucleic Acids Res"},{"key":"4488_CR4","doi-asserted-by":"publisher","first-page":"107498","DOI":"10.1016\/j.intimp.2021.107498","volume":"95","author":"C Chen","year":"2021","unstructured":"Chen C, Wu B, Zhang C, Xu T (2021) Immune-related adverse events associated with immune checkpoint inhibitors: an updated comprehensive disproportionality analysis of the FDA adverse event reporting system. Int Immunopharmacol 95:107498","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4488_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1014471213371","volume":"18","author":"M Corbel","year":"2002","unstructured":"Corbel M, Belleguic C, Boichot E, Lagente V (2002) Involvement of gelatinases (MMP-2 and MMP-9) in the development of airway inflammation and pulmonary fibrosis. Cell Biol Toxicol 18(1):51\u201361","journal-title":"Cell Biol Toxicol"},{"issue":"W1","key":"4488_CR6","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina A, Michielin O, Zoete V (2019) SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res 47(W1):W357\u2013W364","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"4488_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s40264-024-01400-0","volume":"47","author":"M Drent","year":"2024","unstructured":"Drent M, Wijnen PA, Jessurun NT, Harmsze AM, Bekers O, Bast A (2024) Drug-gene risk stratification in patients with suspected drug-induced interstitial lung disease. Drug Saf 47(4):355\u2013363","journal-title":"Drug Saf"},{"issue":"W1","key":"4488_CR8","doi-asserted-by":"publisher","first-page":"W726","DOI":"10.1093\/nar\/gkac297","volume":"50","author":"K Gallo","year":"2022","unstructured":"Gallo K, Goede A, Preissner R, Gohlke B-O (2022) SuperPred 3.0: drug classification and target prediction\u2014a machine learning approach. Nucleic Acids Res 50(W1):W726\u2013W731","journal-title":"Nucleic Acids Res"},{"key":"4488_CR9","doi-asserted-by":"publisher","first-page":"204209862312242","DOI":"10.1177\/20420986231224227","volume":"15","author":"T Jiang","year":"2024","unstructured":"Jiang T, Su H, Xu J et al (2024) Drug-induced interstitial lung disease: a real-world pharmacovigilance study of the FDA Adverse Event Reporting System from 2004 to 2021. Therapeutic Adv Drug Saf 15:20420986231224227","journal-title":"Therapeutic Adv Drug Saf"},{"issue":"1","key":"4488_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1136\/annrheumdis-2021-220493","volume":"81","author":"SM Jung","year":"2022","unstructured":"Jung SM, Park K-S, Kim K-J (2022) Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis 81(1):108\u2013116","journal-title":"Ann Rheum Dis"},{"issue":"15","key":"4488_CR11","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1021\/acs.jcim.3c00687","volume":"63","author":"F Kelleci Celik","year":"2023","unstructured":"Kelleci Celik F, Karaduman G (2023) Machine learning-based prediction of drug-induced hepatotoxicity: an OvA-QSTR approach. J Chem Inf Model 63(15):4602\u20134614","journal-title":"J Chem Inf Model"},{"issue":"4","key":"4488_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.resinv.2013.09.001","volume":"51","author":"K Kubo","year":"2013","unstructured":"Kubo K, Azuma A, Kanazawa M et al (2013) Consensus statement for the diagnosis and treatment of drug-induced lung injuries. Respiratory Invest 51(4):260\u2013277","journal-title":"Respiratory Invest"},{"issue":"suppl2","key":"4488_CR13","doi-asserted-by":"publisher","first-page":"W609","DOI":"10.1093\/nar\/gkq300","volume":"38","author":"X Liu","year":"2010","unstructured":"Liu X, Ouyang S, Yu B et al (2010) PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res 38(suppl2):W609\u2013W614","journal-title":"Nucleic Acids Res"},{"key":"4488_CR14","doi-asserted-by":"publisher","first-page":"905727","DOI":"10.3389\/fimmu.2022.905727","volume":"13","author":"C-Y Lo","year":"2022","unstructured":"Lo C-Y, Wang C-H, Wang C-W et al (2022) Increased interleukin-17 and glucocorticoid receptor-\u03b2 expression in interstitial lung diseases and corticosteroid insensitivity. Front Immunol 13:905727","journal-title":"Front Immunol"},{"key":"4488_CR15","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3389\/fphys.2020.00584","volume":"11","author":"I Mahmutovic Persson","year":"2020","unstructured":"Mahmutovic Persson I, Falk H\u00e5kansson H, \u00d6rbom A, Liu J, von Wachenfeldt K, Olsson LE (2020) Imaging biomarkers and pathobiological profiling in a rat model of drug-induced interstitial lung disease induced by bleomycin. Front Physiol 11:584","journal-title":"Front Physiol"},{"issue":"780","key":"4488_CR16","doi-asserted-by":"publisher","first-page":"eadk8623","DOI":"10.1126\/scitranslmed.adk8623","volume":"17","author":"AS McCall","year":"2025","unstructured":"McCall AS, Gutor S, Tanjore H et al (2025) Hypoxia-inducible factor 2 regulates alveolar regeneration after repetitive injury in three-dimensional cellular and in vivo models. Sci Transl Med 17(780):eadk8623","journal-title":"Sci Transl Med"},{"issue":"5","key":"4488_CR17","doi-asserted-by":"publisher","first-page":"e13331","DOI":"10.1111\/ijcp.13331","volume":"73","author":"L Meng","year":"2019","unstructured":"Meng L, Huang J, Jia Y, Huang H, Qiu F, Sun S (2019) Assessing fluoroquinolone-associated aortic aneurysm and dissection: data mining of the public version of the FDA adverse event reporting system. Int J Clin Pract 73(5):e13331","journal-title":"Int J Clin Pract"},{"key":"4488_CR18","doi-asserted-by":"publisher","first-page":"655605","DOI":"10.3389\/fphar.2021.655605","volume":"12","author":"H Nawa","year":"2021","unstructured":"Nawa H, Niimura T, Hamano H et al (2021) Evaluation of potential complications of interstitial lung disease associated with antiandrogens using data from databases reporting spontaneous adverse effects. Front Pharmacol 12:655605","journal-title":"Front Pharmacol"},{"issue":"3","key":"4488_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/bcp.15953","volume":"90","author":"T Noda","year":"2024","unstructured":"Noda T, Mizuno S, Mogushi K et al (2024) Development of a predictive model for nephrotoxicity during tacrolimus treatment using machine learning methods. Br J Clin Pharmacol 90(3):675\u2013683","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"4488_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10549-020-06001-w","volume":"186","author":"E Raschi","year":"2021","unstructured":"Raschi E, Fusaroli M, Ardizzoni A, Poluzzi E, De Ponti F (2021) Cyclin-dependent kinase 4\/6 inhibitors and interstitial lung disease in the FDA adverse event reporting system: a pharmacovigilance assessment. Breast Cancer Res Treat 186(1):219\u2013227","journal-title":"Breast Cancer Res Treat"},{"key":"4488_CR21","doi-asserted-by":"crossref","unstructured":"Safran M, Dalah I, Alexander J et al (2010) GeneCards Version 3: the human gene integrator. Database 2010","DOI":"10.1093\/database\/baq020"},{"issue":"2","key":"4488_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1021\/ci500588j","volume":"55","author":"T Sander","year":"2015","unstructured":"Sander T, Freyss J, Von Korff M, Rufener C (2015) DataWarrior: an open-source program for chemistry aware data visualization and analysis. J Chem Inf Model 55(2):460\u2013473","journal-title":"J Chem Inf Model"},{"issue":"1","key":"4488_CR23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1186\/s12967-023-04756-6","volume":"21","author":"K Shimoji","year":"2023","unstructured":"Shimoji K, Nakashima T, Masuda T et al (2023) Hypoxia-inducible factor 1\u03b1 modulates interstitial pneumonia-mediated lung cancer progression. J Translational Med 21(1):857","journal-title":"J Translational Med"},{"issue":"10","key":"4488_CR24","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/jcm7100356","volume":"7","author":"S Skeoch","year":"2018","unstructured":"Skeoch S, Weatherley N, Swift AJ et al (2018) Drug-induced interstitial lung disease: a systematic review. J Clin Med 7(10):356","journal-title":"J Clin Med"},{"key":"4488_CR25","doi-asserted-by":"crossref","unstructured":"Spagnolo P, Bonniaud P, Rossi G, Sverzellati N, Cottin V (2022) Drug-induced interstitial lung disease. Eur Respir J 60(4)","DOI":"10.1183\/13993003.02776-2021"},{"key":"4488_CR26","first-page":"420","volume":"21","author":"Studio D","year":"2008","unstructured":"Studio D (2008) Discovery studio. Accelrys 21:420","journal-title":"Accelrys"},{"issue":"12","key":"4488_CR27","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jamaoncol.2021.3595","volume":"7","author":"P Tarantino","year":"2021","unstructured":"Tarantino P, Modi S, Tolaney SM et al (2021) Interstitial lung disease induced by anti-ERBB2 antibody-drug conjugates: a review. JAMA Oncol 7(12):1873\u20131881","journal-title":"JAMA Oncol"},{"issue":"8","key":"4488_CR28","doi-asserted-by":"publisher","first-page":"103658","DOI":"10.1016\/j.esmoop.2024.103658","volume":"9","author":"D Trapani","year":"2024","unstructured":"Trapani D, Scalia R, Giordano E et al (2024) Interstitial lung disease in patients enrolled in early-phase clinical trials: the ILDE study. ESMO open 9(8):103658","journal-title":"ESMO open"},{"issue":"2","key":"4488_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461","journal-title":"J Comput Chem"},{"issue":"16","key":"4488_CR30","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","volume":"26","author":"D Van Der Spoel","year":"2005","unstructured":"Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ (2005) GROMACS: fast, flexible, and free. J Comput Chem 26(16):1701\u20131718","journal-title":"J Comput Chem"},{"issue":"7","key":"4488_CR31","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/jcc.21707","volume":"32","author":"CW Yap","year":"2011","unstructured":"Yap CW (2011) PaDEL-descriptor: An open source software to calculate molecular descriptors and fingerprints. J Comput Chem 32(7):1466\u20131474","journal-title":"J Comput Chem"},{"issue":"1","key":"4488_CR32","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12989-022-00483-w","volume":"19","author":"R Zhang","year":"2022","unstructured":"Zhang R, Chen S, Chen L et al (2022) Single-cell transcriptomics reveals immune dysregulation mediated by IL-17A in initiation of chronic lung injuries upon real-ambient particulate matter exposure. Part Fibre Toxicol 19(1):42","journal-title":"Part Fibre Toxicol"},{"key":"4488_CR34","doi-asserted-by":"crossref","unstructured":"Zhao Y, Wan Q, He X (2024) Construction of IRAK4 inhibitor activity prediction model based on machine learning. Mol Diversity 1\u201312","DOI":"10.1007\/s11030-024-10926-5"},{"key":"4488_CR33","doi-asserted-by":"crossref","unstructured":"Zhao Y, Chen Y, Tao X, Wang Y, Tang F (2025) An integrated approach for novel PTP1B inhibitor screening: combining machine learning models, molecular docking, molecular and dynamics simulations. Mol Diversity 1\u201313","DOI":"10.1007\/s11030-025-11292-6"},{"key":"4488_CR35","doi-asserted-by":"crossref","unstructured":"Zuo X, Hou X, Tan S et al (2026) Network toxicology and multi-omics analyses identify diagnostic genes and elucidate underlying mechanisms of 6PPDQ-induced hepatocellular carcinoma. Environ Pollut 127632","DOI":"10.1016\/j.envpol.2026.127632"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04488-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04488-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-026-04488-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:02:05Z","timestamp":1792846925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-026-04488-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4488"],"URL":"https:\/\/doi.org\/10.1007\/s00204-026-04488-8","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial or personal interests that could have influenced the outcomes or interpretation of this work.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}